Skip to main content

Latest SEC Filings — Page 154

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

OneMeta Q2 Loss Widens to $2.27M; Going Concern Doubt and Control Weaknesses Disclosed
ProForm 10-QONEI · Form 10-Q · 2026-08-14
Reading International Returns to Profit in Q2, Alleviates Going Concern Doubt Amidst Major Debt Maturities
ProForm 10-QRDI · Form 10-Q · 2026-08-14
Emmaus Life Sciences Q2 2026: Net Income Reaches $1.3M as Revenue Jumps 124%
Form 8-KEMMA · Form 8-K · 2026-08-14
HCW Biologics Restates Q1 EPS Down 37% to $1.39, Cites Unremediated Material Weakness
ProForm 10-Q/AHCWB · Form 10-Q/A · 2026-08-14
OSR Health's Q2 Loss, Unremediated Material Weaknesses, and Shrinking Cash
ProForm 10-QOSRH · Form 10-Q · 2026-08-14
SEII 10-Q Reveals Going Concern Doubt, $179K Loss, and 5B Share Reverse Merger Details
ProForm 10-QSEII · Form 10-Q · 2026-08-14
Nu-Med Plus Advances Gold Pivot: Vendor Approves Property Purchase, Closing Expected Shortly
ProForm 10-QNUMD · Form 10-Q · 2026-08-14
BONK Posts $7.9M H1 Loss, Cash Drops to $214K, Going Concern Warning Reiterated
ProForm 10-QBNKK · Form 10-Q · 2026-08-14
SportsQuest Q2 2026: Going Concern Warning Reiterated, Cash at $15K
ProForm 10-QSPQS · Form 10-Q · 2026-08-14
HCW Biologics Restates Q1 EPS Down 37% on Accounting Error
ProForm 8-KHCWB · Form 8-K · 2026-08-14
WEED, Inc. Q2 2026: Cash Dwindles to $1,066, Going Concern Warning Reaffirmed
ProForm 10-QBUDZ · Form 10-Q · 2026-08-14
AmeriServ Financial Reports Strong Q2 Earnings Turnaround, Improved Credit Quality
ProForm 10-QASRV · Form 10-Q · 2026-08-14
TransAct Q2 2026: Tariff Refund Accounting and Strategic Review Details
Form 10-QTACT · Form 10-Q · 2026-08-14
BluSky AI Q2 2026: Going Concern Warning, Ineffective Controls, and Reg A Dilution
ProForm 10-QBSAI · Form 10-Q · 2026-08-14
United Health Products Q2 2026: Cash Drops to $24K, Going Concern Warning Reiterated
ProForm 10-QUEEC · Form 10-Q · 2026-08-14
ADM Endeavors Q2 10-Q: Losses, a Toxic Convertible Note, and CEO Credit Lines
ProForm 10-QADMQ · Form 10-Q · 2026-08-14
Elvictor Q2 2026: Net Income $114.5K, But Going Concern Doubt Persists
ProForm 10-QELVG · Form 10-Q · 2026-08-14
Kustom Entertainment Flags $10.4M H1 Loss, Going Concern Doubt, and Nasdaq Equity Shortfall
ProForm 10-QKUST · Form 10-Q · 2026-08-14
Goldenwell Biotech Q2 2026: Zero Revenue, Cash Down to $11K, Going Concern Doubts Deepen
ProForm 10-QGWLL · Form 10-Q · 2026-08-14
KwikClick Q2 Revenue Jumps 320% but Going Concern Doubt Persists
ProForm 10-QKWIK · Form 10-Q · 2026-08-14
BILI Social Reports Q2 Profit, Alleviates Going Concern, But Discloses Material Weaknesses
ProForm 10-QAGGI · Form 10-Q · 2026-08-14
Going Concern Doubt, Zero Cash, and $6.3M Liabilities at Atlantica Inc.
ProForm 10-QALDA · Form 10-Q · 2026-08-14
Alpha Modus Reports $6.2M Loss, Ineffective Controls, and Going Concern Doubt
ProForm 10-QAMOD · Form 10-Q · 2026-08-14
1606 Corp. Reports $1.19M Loss, $288 Cash, and Going Concern Doubts
ProForm 10-QCBDW · Form 10-Q · 2026-08-14
BayFirst Q2 Loss Hits $32.7M on $41.5M Asset Resolution Charge; Material Weakness Disclosed
ProForm 10-QBAFN · Form 10-Q · 2026-08-14
Emmaus Life Sciences Flags Going Concern Doubt, Material Weaknesses in Q2 10-Q
ProForm 10-QEMMA · Form 10-Q · 2026-08-14
Chilean Cobalt Updates $51.87M Resale Offering with Q2 10-Q Showing New $375M EXIM LOI and Going Concern
ProForm 424B3COBA · Form 424B3 · 2026-08-14
Boxlight's Q2 profit masks going concern and Nasdaq delisting risk
ProForm 10-QBOXL · Form 10-Q · 2026-08-14
Bleichroeder LP Discloses 33.2% Stake in MDxHealth After $20M Offering
Form SCHEDULE 13DMDXH · Form SCHEDULE 13D · 2026-08-14
Davis Commodities Receives Nasdaq Final Delisting Action
ProForm 6-KDTCKF · Form 6-K · 2026-08-14